Niva Bupa Q1 FY27: Profit Up, Retail Growth Strong, CISR Improves
Niva Bupa Health Insurance reported Q1 FY27 Profit After Tax of ₹137.8 crore and improved CISR to 100.2%. Retail health business saw strong growth of 47.1%, increasing market share to 11.1%. The company is transitioning to Ind AS and exploring debt raising up to ₹500 crore. Its solvency ratio is 2.25.
The strong growth in retail health, improved profitability, and market share gains are significant positive developments that are likely to impact investor sentiment and the company's market position.
The company reported improved profitability, strong growth in its key segment (retail health), and a healthier combined insurance service ratio, all indicating positive financial and operational performance.
Niva Bupa Health Insurance Company Limited has announced its financial and business performance for the quarter ended June 30, 2026. The company reported a Profit After Tax of ₹137.8 crore, a significant improvement compared to the previous year. The combined insurance service ratio (CISR) also saw a notable increase, moving to 100.2% from 103.2% in the same quarter last year.
The company experienced robust growth in its retail health segment, with a reported growth of 47.1% and a like-to-like growth of 35.5%. This has led to an increase in its retail market share to 11.1% for Q1. In contrast, the group business saw flat growth due to a challenging pricing environment.
Niva Bupa has fully transitioned to the Ind AS accounting standard, while continuing to report parallel accounts as required. The company also highlighted its progress on industry initiatives, including awareness campaigns and standardization efforts in health insurance.
Financially, the post-tax Return on Equity (ROE) for the last four rolling quarters stood at 11.8%. The solvency ratio remained healthy at 2.25 as of June 30, 2026, well above the regulatory minimum of 1.50. The company's board has approved the formation of a debt-raising committee with the ability to raise up to ₹500 crore.
In terms of operational performance, Niva Bupa was ranked 41st among the top 50 Great Places to Work. Net Promoter Scores (NPS) improved to 62 from 57 last year, reflecting positive customer feedback. The claims settlement rate also improved to 95.6% in Q1.
The company continues to execute its health partner and Preferred Provider Network (PPN) strategies, with the PPN now present in 49 cities and encompassing over 1,000 hospitals, contributing to guiding customers to appropriate care settings and potentially reducing claim costs.
What to do with a filing like this
Niva Bupa Health Insurance Company Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Niva Bupa Health Insurance Company Limited. Read the original for the full detail.